These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 4669450)
1. On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using "proportional reduction" of dietary phosphorus intake. Slatopolsky E; Caglar S; Gradowska L; Canterbury J; Reiss E; Bricker NS Kidney Int; 1972 Sep; 2(3):147-51. PubMed ID: 4669450 [No Abstract] [Full Text] [Related]
2. The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease. Slatopolsky E; Bricker NS Kidney Int; 1973 Aug; 4(2):141-5. PubMed ID: 4355426 [No Abstract] [Full Text] [Related]
3. Disordered divalent ion metabolism in kidney disease: comments on pathogenesis and treatment. Kleeman CR; Better OS Kidney Int; 1973 Aug; 4(2):73-9. PubMed ID: 4364428 [No Abstract] [Full Text] [Related]
4. [Secondary hyperparathyroidism in renal insufficiency. Prevention and therapy]. Malluche HH; Ritz E MMW Munch Med Wochenschr; 1976 Jan; 118(5):129-30. PubMed ID: 814442 [No Abstract] [Full Text] [Related]
5. Hyperparathyroidism and renal failure. Arnaud CD Kidney Int; 1973 Aug; 4(2):89-95. PubMed ID: 4598144 [No Abstract] [Full Text] [Related]
9. Calcium and phosphorus in diet therapy of uremia. Schoolwerth AC; Engle JE J Am Diet Assoc; 1975 May; 66(5):460-4. PubMed ID: 1123506 [TBL] [Abstract][Full Text] [Related]
10. Prevention of enhanced parathyroid hormone secretion, synthesis and hyperplasia by mild dietary phosphorus restriction in early chronic renal failure in rats: possible direct role of phosphorus. Yi H; Fukagawa M; Yamato H; Kumagai M; Watanabe T; Kurokawa K Nephron; 1995; 70(2):242-8. PubMed ID: 7566311 [TBL] [Abstract][Full Text] [Related]
11. Secondary hyperparathyroidism in severe chronic renal failure is corrected by very-low dietary phosphate intake and calcium carbonate supplementation. Barsotti G; Cupisti A; Morelli E; Meola M; Cozza V; Barsotti M; Giovannetti S Nephron; 1998; 79(2):137-41. PubMed ID: 9647491 [TBL] [Abstract][Full Text] [Related]
12. Calcium and phosphate metabolism in chronic renal failure, with particular reference to the effect of 1 alpha-hydroxyvitamin D3. Madsen S Acta Med Scand Suppl; 1980; 638():3-120. PubMed ID: 6929650 [No Abstract] [Full Text] [Related]
13. Genesis of hyperparathyroidism. Reiss E; Canterbury JM Am J Med; 1971 May; 50(5):679-85. PubMed ID: 4932833 [No Abstract] [Full Text] [Related]
14. Skeletal resistance to the calcaemic action of parathyroid hormone in uraemia: a mechanism for the hypocalcaemia and secondary hyperparathyroidism of chronic renal failure. Massry SG Clin Endocrinol (Oxf); 1976; 5 Suppl():317S-325S. PubMed ID: 1052781 [No Abstract] [Full Text] [Related]
15. Reversal of hyperparathyroidism in response to dietary phosphorus restriction in the uremic dog. Kaplan MA; Canterbury JM; Bourgoignie JJ; Veliz G; Gavellas G; Reiss E; Bricker NS Kidney Int; 1979 Jan; 15(1):43-8. PubMed ID: 491396 [No Abstract] [Full Text] [Related]
16. Sevelamer hydrochloride suppresses proliferation of parathyroid cells during the early phase of chronic renal failure in rats. Xiao X; Liu Y; Zhong X; Liu Y; Zhou D; Xiong X; Ran J Nephrology (Carlton); 2019 Jan; 24(1):127-133. PubMed ID: 29278442 [TBL] [Abstract][Full Text] [Related]